PL336847A1 - Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailability - Google Patents

Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailability

Info

Publication number
PL336847A1
PL336847A1 PL98336847A PL33684798A PL336847A1 PL 336847 A1 PL336847 A1 PL 336847A1 PL 98336847 A PL98336847 A PL 98336847A PL 33684798 A PL33684798 A PL 33684798A PL 336847 A1 PL336847 A1 PL 336847A1
Authority
PL
Poland
Prior art keywords
improved
sulphate
oral administration
protease inhibitor
hiv protease
Prior art date
Application number
PL98336847A
Other languages
English (en)
Inventor
David Askin
R Scott Hoerrner
Robert M Purick
Paul Reider
Richard J Varsolona
Ralph P Volante
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9714320.0A external-priority patent/GB9714320D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PL336847A1 publication Critical patent/PL336847A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL98336847A 1997-05-29 1998-05-26 Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailability PL336847A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4795097P 1997-05-29 1997-05-29
GBGB9714320.0A GB9714320D0 (en) 1997-07-07 1997-07-07 Hiv protease inhibitor

Publications (1)

Publication Number Publication Date
PL336847A1 true PL336847A1 (en) 2000-07-17

Family

ID=26311845

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98336847A PL336847A1 (en) 1997-05-29 1998-05-26 Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailability

Country Status (22)

Country Link
EP (1) EP0986554A1 (is)
JP (1) JP3267632B2 (is)
KR (1) KR20010013042A (is)
CN (1) CN1257497A (is)
AU (1) AU730245B2 (is)
BG (1) BG103923A (is)
BR (1) BR9809498A (is)
CA (1) CA2291086A1 (is)
EA (1) EA199901095A1 (is)
EE (1) EE9900543A (is)
HR (1) HRP980283A2 (is)
HU (1) HUP0004621A3 (is)
ID (1) ID23858A (is)
IL (1) IL132779A0 (is)
IS (1) IS5240A (is)
NO (1) NO995822L (is)
PE (1) PE75099A1 (is)
PL (1) PL336847A1 (is)
SK (1) SK163299A3 (is)
TR (1) TR199902816T2 (is)
TW (1) TW438799B (is)
WO (1) WO1998054178A1 (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU777824B2 (en) * 1999-11-24 2004-11-04 Merck Sharp & Dohme Corp. Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1- piperazinepentanamides as HIV protease inhibitors
US20020082421A1 (en) * 2000-09-14 2002-06-27 Abdel-Magid Ahmed F. Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3000564B2 (ja) * 1993-12-15 2000-01-17 メルク エンド カンパニー インコーポレーテッド Ｈｉｖプロテアーゼ阻害剤

Also Published As

Publication number Publication date
EE9900543A (et) 2000-06-15
HUP0004621A2 (hu) 2002-03-28
HUP0004621A3 (en) 2002-04-29
EA199901095A1 (ru) 2000-08-28
BG103923A (en) 2000-06-30
NO995822D0 (no) 1999-11-26
AU730245B2 (en) 2001-03-01
IS5240A (is) 1999-11-09
TR199902816T2 (xx) 2000-02-21
JP2000513747A (ja) 2000-10-17
JP3267632B2 (ja) 2002-03-18
EP0986554A1 (en) 2000-03-22
AU7595998A (en) 1998-12-30
PE75099A1 (es) 1999-08-11
WO1998054178A1 (en) 1998-12-03
KR20010013042A (ko) 2001-02-26
SK163299A3 (en) 2000-07-11
ID23858A (id) 2000-05-25
HRP980283A2 (en) 1999-08-31
NO995822L (no) 2000-01-28
CN1257497A (zh) 2000-06-21
TW438799B (en) 2001-06-07
CA2291086A1 (en) 1998-12-03
IL132779A0 (en) 2001-03-19
BR9809498A (pt) 2000-06-20

Similar Documents

Publication Publication Date Title
NL300952I2 (nl) Peramivir en farmaceutisch aanvaardbare zouten daarvan
IL137445A0 (en) Pharmaceutically active compounds and methods of use thereof
IL141155A0 (en) Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
HUP0002744A3 (en) Rapidly releasing and taste-masking pharmaceutical dosage form
AP2000001757A0 (en) Solid oral dosage form comprising a combination of metforming and glibenclamide
HUP0100900A3 (en) Pharmaceutically active morpholinol and medicaments containing them
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
PL341428A1 (en) Oral pharmacological dosage form of prolonged release type
ZA986893B (en) Oral pharmaceutical preparation which includes a compound of anti-ulcer activity and procedure for making same
EP1071403A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING STATIN AND ASPIRIN
HUP0002209A3 (en) 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
HUP0003133A3 (en) Ace-inhibitor nitric salts and use of them for producing pharmaceutical compositions
HUP0202862A3 (en) Pharmaceutical composition containing novel combination of loteprednol and antihistamines
EP1115396A4 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS, AND METHODS OF USE THEREOF
GB2343117B (en) Benzimidazole pharmaceutical composition and process of preparation
GB9808840D0 (en) Treatment of depression and pharmaceutical preparations therefor
GB9507415D0 (en) Production and uses of caffeic acid and derivatives thereof
ZA984966B (en) Crystal modification of a pharmaceutical agent
PL337513A1 (en) Novel method of obtaining pharmaceutically active compounds and their associated intermediate products
PL336847A1 (en) Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailability
EP0996441A4 (en) PHARMACEUTICAL COMPOSITIONS OF ARGLABIN AND ARGLABIN DERIVATIVES
HUP0105097A3 (en) Pharmaceutical mixtures comprising a combination of a profen and other active compounds
IL108881A0 (en) Pharmaceutical compositions containing a combination of verapamil and trandolapril
EP1041986A4 (en) PHARMACEUTICAL ACTIVE COMPOUND AND METHODS OF USE